SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
GlaxoSmithKline and Theravance, Inc. Announce FDA Acceptance of New Drug Application (NDA) Submission in the U.S. for ANORO ELLIPTA™ for COPD